| beta-LP | beta-lapachone |
| CD | cyclodextrins |
| DLS | dynamic light scattering |
| DOX | doxorubicin |
| FA | folic acid |
| FR | folate receptor |
| FTIR | Fourier-transform infrared spectroscopy |
| IC 50 | half maximal inhibitory concentration |
| NMR | nuclear magnetic resonance spectroscopy |
| PBS | phosphate-buffered saline |
| PEI | polyethylenimine |
| PEI-αCD | nanoconjugate of polyethylenimine with alpfa cyclodextrins |
| PEI-βCD | nanoconjugate of polyethylenimine with beta cyclodextrins |
| PEI-βCD-αCD-FA | nanoconjugate of polyethylenimine with alpha and beta cyclodextrins and folic acid |
| PEI-βCD(DOX)-αCD(beta-LP)-FA | nanoconjugate of polyethylenimine with alpha and beta cyclodextrins and folic acid loaded with doxorubicin and beta-lapachone |
| QCM-D | quartz crystal microbalance with dissipation monitoring |
| ZP | zeta potential |